Circulatory Epigenetic Signatures: A Promise for Early Detection of Cancer, Cardiovascular and Neurodevelopmental Diseases

  • 2,377

    Total downloads

  • 9,534

    Total views and downloads

About this Research Topic

Submission closed

Background

Alterations in one-carbon metabolism cycle may be in charge of abnormal DNA methylation processes, which could result in a number of human disorders. Accumulating evidence indicates that many human diseases with multi-factorial origin may also have an epigenetic basis and it has been possible to map the epigenetic signatures of diagnostic/prognostic relevance with the advancement of methods to study them.

Epigenetic alterations including aberrant DNA methylation, histone modification, and dysregulated expression of miRNAs play a significant part in cancer initiation and progression. CpG island hypermethylation is a putative method for the inactivation of tumour suppressor genes by transcriptional silencing. Tumour specific aberrant promoter hypermethylation of genes is a frequent early event in cancer which may be detected in body fluids and has been found in patients with several tumour types, including lung, prostate, breast, and colorectal cancer. In both early-stage and advanced-stage cancers circulating cell free DNA levels (CFDNA) in serum are unusually high, therefore liquid biopsy-based approaches provide an accurate and noninvasive method for early-stage detection of solid and liquid cancer. Cells in cancer tissue may opt for any two mechanisms, either they undergo in situ apoptosis and/or necrosis or they may separate from tumours and extravagate into the circulation and lysed. Thus, aberrant DNA methylation patterns in body fluids/liquid biopsies can be indicative of disease presence and may be used as a biomarker for the diagnosis and treatment of cancer patients.

The onset and progression of neurodegenerative/neurodevelopmental and other age-related diseases may be significantly influenced by environmental factors, according to DNA methylation studies based on transgenic Alzheimer's disease mouse models, which revealed genome-wide hypomethylation in these patients. These mice models showed severe learning and memory deficits as well as reduced synaptic plasticity due to downregulation of DNMT3a mRNA levels in various somatic, germinal, and serum samples. Reduced global hypomethylation could therefore be a useful new diagnostic biomarker for many common disorders. In case of traumatic brain injury (TBI), the blood–brain barrier gets impaired and leaky resulting cell free nucleic acids as potential biomarkers. Neurodegenerative disorders have also been linked to variations in both global and locus-specific levels of5mC and 5hmC.

Epigenetic regulation is crucial in the pathogenesis of cardiovascular diseases like hypertension and atherosclerosis, and recent advances on the alteration, regulation, and implication of histone modifications and DNA methylation in cardiac injury and heart dysfunction will pave a way towards novel diagnostic approaches leading to improvement of survival rates. Circulating miRNAs have been recognized as critical biomarkers for myocardial infarction, coronary heart disease, and heart failure. Also, they have been identified to govern pulmonary vascular alterations related to the onset of pulmonary arterial hypertension and/or influence cellular responses to hypoxia. On the other hand, circulating long ncRNAs serve as specific and sensitive biomarkers for not only cardiovascular disease but also therapeutic response. Together, these data provide credence to the idea that epigenetic changes can affect risk for complex diseases.

Cellular identity and function depend on the precise expression of genes. Different epigenetic mechanisms control the chromatin structure and DNA accessibility to the transcriptional machinery, including DNA methylation, histone modifications, non-coding RNA expressions, and miRNA expressions. Numerous disease pathogenesis disorders have been linked to altered epigenetic signatures and mechanisms. Personalized epigenetic maps for diagnosis and treatment are strengthened by new epigenetic signatures, mechanisms and targets involved in diseases such as cancer, neurodevelopmental disorders and cardiovascular diseases, according to studies. As a result, we suggest that Original research papers and reviews focusing on the use of circulating epigenetic signatures as therapeutic targets and biomarkers for diagnosis will be considered for this Research Topic. Further, manuscripts exploring the epigenetic signatures/markers and mechanisms involved in solid and liquid cancers, neurodevelopmental disorders and cardiovascular disease diagnosis and treatment are encouraged.

The goal of this article collection is to compile the results of research in the fields connected to the role and applications of circulatory epigenetic signatures in early detection of Cancer, Cardiovascular and Neurodevelopmental Disorders. Submission of papers having clear ties to related topics is greatly encouraged. Before being accepted, the contributions to this collection will go through peer review.

Keywords: epigenetics, cancer, cardiovascular disease, neurodevelopmental disorder, therapeutic target, circulatory epigenetic signature

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.